A perspective of sensor-augmented insulin pump therapy in the treatment of type 1 diabetes
The holy grail for the treatment of type 1 diabetes is stem cell therapy (1,2) or the closed-loop artificial pancreas (3,4). Whereas several groups are currently developing these treatment modalities, they are not there yet. The first step in the process has been met with the low-glucose suspend pum...
Saved in:
Published in | Endocrine practice Vol. 21; no. 1; pp. 91 - 92 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The holy grail for the treatment of type 1 diabetes is stem cell therapy (1,2) or the closed-loop artificial pancreas (3,4). Whereas several groups are currently developing these treatment modalities, they are not there yet. The first step in the process has been met with the low-glucose suspend pump, which stops insulin delivery for up to 2 hours when the interstitial glucose concentration reaches 70 mg/dL. The Diabetes Control and Complications Trial first showed a clear relationship between diabetic microvascular complications and glycemic control. Others have posited data supporting a relationship between macrovascular disease and glycemic control. In addition to achieving an optimum glycated hemoglobin (HbA1c) level of <6.5% (AACE), or <7.0% (ADA, EASD), one should not forget the role of glycemic variability. Not only does a minimal degree of glycemic variability improve the patient's quality of life, but increased glycemic variability correlates with the urinary excretion of 8-iso prostaglandin F2α, increased oxidative stress, and a presumed increase in the rate of diabetic complication. |
---|---|
AbstractList | The holy grail for the treatment of type 1 diabetes is stem cell therapy (1,2) or the closed-loop artificial pancreas (3,4). Whereas several groups are currently developing these treatment modalities, they are not there yet. The first step in the process has been met with the low-glucose suspend pump, which stops insulin delivery for up to 2 hours when the interstitial glucose concentration reaches 70 mg/dL. The Diabetes Control and Complications Trial first showed a clear relationship between diabetic microvascular complications and glycemic control. Others have posited data supporting a relationship between macrovascular disease and glycemic control. In addition to achieving an optimum glycated hemoglobin (HbA1c) level of <6.5% (AACE), or <7.0% (ADA, EASD), one should not forget the role of glycemic variability. Not only does a minimal degree of glycemic variability improve the patient's quality of life, but increased glycemic variability correlates with the urinary excretion of 8-iso prostaglandin F2α, increased oxidative stress, and a presumed increase in the rate of diabetic complication. |
Author | Rayfield, Elliot J |
Author_xml | – sequence: 1 givenname: Elliot J surname: Rayfield fullname: Rayfield, Elliot J organization: Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25297673$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkMtKw0AUhgep2ItufAAZcCNCauaWSZYl1AsU6kJB3IRJckZTkkmcmQh9exNaXbg6P4fv_By-OZqY1gBClyRcciLiu_Uz4ZyzZbo9QTOSMB5QHrLJkAULgzghb1M0d24XhjRMSHyGplTQREaSzdD7CndgXQeFr74Btxo7MK61geo_GjAeSlwZ19eVwV3fdNh_glXdfliOEXsLyo_ceOn3HWCCy0rl4MGdo1OtagcXx7lAr_frl_Qx2GwfntLVJiio5D7gnESa6TwHmUQJcFXEWgqeR1opKEGEJCFS0ViQkikZg4h1kZRMC1ZIrUXMFujm0NvZ9qsH57OmcgXUtTLQ9i4jkaCcUkL5gF7_Q3dtb83w3UgxKQd5bKBuD1RhW-cs6KyzVaPsPiNhNhrPjsazdDvAV8fKPm-g_EN_FbMfgId9Qw |
Cites_doi | 10.1186/1475-2840-1-1 10.2337/dc08-s241 10.1177/1932296814532203 10.2337/db12-0018 10.4158/EP14187.OR 10.1177/0145721709333493 10.2337/dc11-1248 10.1073/pnas.1400709111 10.1056/NEJMoa1002853 10.1056/NEJMoa1314474 10.2337/dc12-1965 10.1056/NEJMoa1303576 10.1089/dia.2013.0049 |
ContentType | Journal Article |
Copyright | Copyright Allen Press Publishing Services Jan 2015 |
Copyright_xml | – notice: Copyright Allen Press Publishing Services Jan 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88C 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH K9- K9. KB0 M0R M0S M0T M1P NAPCQ PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.4158/EP14443.CO |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database (ProQuest) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Family Health Database (Proquest) Health & Medical Collection (Alumni Edition) Health Management Database (Proquest) PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Essentials |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1934-2403 |
EndPage | 92 |
ExternalDocumentID | 3586599001 10_4158_EP14443_CO 25297673 |
Genre | Comment Journal Article Commentary |
GroupedDBID | --- 0R~ 3V. 4.4 53G 5GY 7RV 7X7 88E 8FI 8FJ AALRI AAQQT AAXUO ABJNI ABUWG ADBBV AENEX AFJKZ AFKRA AHMBA AITUG ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ AQUVI AZQEC BENPR BKEYQ BKNYI BPHCQ BVXVI CCPQU CGR CUY CVF EBS ECM EIF EJD F5P FDB FYUFA K9- M0R M0T M1P MAS MCE MET NAPCQ NPM OVD P2P PQQKQ PROAC PSQYO ROL SV3 TEORI AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c274t-4416f3fbbe7969e4ac8f754b6faaede501917a2851d3a78e58fc9d3f53c7ff583 |
IEDL.DBID | BENPR |
ISSN | 1530-891X |
IngestDate | Fri Aug 16 01:33:02 EDT 2024 Thu Oct 10 20:04:25 EDT 2024 Thu Sep 26 16:30:39 EDT 2024 Sat Sep 28 08:24:56 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c274t-4416f3fbbe7969e4ac8f754b6faaede501917a2851d3a78e58fc9d3f53c7ff583 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1 |
PMID | 25297673 |
PQID | 1653779343 |
PQPubID | 1896353 |
PageCount | 2 |
ParticipantIDs | proquest_miscellaneous_1652422124 proquest_journals_1653779343 crossref_primary_10_4158_EP14443_CO pubmed_primary_25297673 |
PublicationCentury | 2000 |
PublicationDate | 2015-Jan 2015-00-00 20150101 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-Jan |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Jacksonville |
PublicationTitle | Endocrine practice |
PublicationTitleAlternate | Endocr Pract |
PublicationYear | 2015 |
Publisher | Elsevier Limited |
Publisher_xml | – name: Elsevier Limited |
References | 25100386 - Endocr Pract. 2015 Jan;21(1):41-5 Hrvatin (10.4158/EP14443.CO_bb0005) 2014; 111 Damiano (10.4158/EP14443.CO_bb0070) 2014 Monnier (10.4158/EP14443.CO_bb0040) 2008; 31 Kovatchev (10.4158/EP14443.CO_bb0020) 2013; 36 Bergenstal (10.4158/EP14443.CO_bb0025) 2013; 369 Luijf (10.4158/EP14443.CO_bb0065) 2013; 15 Bergenstal (10.4158/EP14443.CO_bb0045) 2010; 363 Tanenberg (10.4158/EP14443.CO_bb0055) 2015; 21 (10.4158/EP14443.CO_bb0030) 1993; 329 Bergenstal (10.4158/EP14443.CO_bb0050) 2011; 34 Kulkarni (10.4158/EP14443.CO_bb0010) 2012; 61 Russell (10.4158/EP14443.CO_bb0015) 2014; 371 Aronson (10.4158/EP14443.CO_bb0035) 2002; 1 Schemer (10.4158/EP14443.CO_bb0060) 2009; 35 |
References_xml | – volume: 1 start-page: 1 year: 2002 ident: 10.4158/EP14443.CO_bb0035 article-title: How hyperglycemia promotes atherosclerosis: molecular mechanisms publication-title: Cardiovasc Diabetol. doi: 10.1186/1475-2840-1-1 contributor: fullname: Aronson – volume: 31 start-page: S150 issue: suppl 2 year: 2008 ident: 10.4158/EP14443.CO_bb0040 article-title: Glycemic variability: should we and can we prevent it? publication-title: Diabetes Care. doi: 10.2337/dc08-s241 contributor: fullname: Monnier – year: 2014 ident: 10.4158/EP14443.CO_bb0070 article-title: A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite publication-title: J Diabetes Sci Technol doi: 10.1177/1932296814532203 contributor: fullname: Damiano – volume: 61 start-page: 2205 year: 2012 ident: 10.4158/EP14443.CO_bb0010 article-title: Human p-cell proliferation and intracellular signaling: driving in the dark without a road map publication-title: Diabetes. doi: 10.2337/db12-0018 contributor: fullname: Kulkarni – volume: 329 start-page: 978 year: 1993 ident: 10.4158/EP14443.CO_bb0030 publication-title: N Engl J Med. – volume: 21 start-page: 41 year: 2015 ident: 10.4158/EP14443.CO_bb0055 article-title: Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the STAR 3 study publication-title: Endocr Pract. doi: 10.4158/EP14187.OR contributor: fullname: Tanenberg – volume: 35 start-page: 29S issue: suppl 2 year: 2009 ident: 10.4158/EP14443.CO_bb0060 article-title: Insulin pump therapy: guidelines for successful outcomes publication-title: Diabetes Educ doi: 10.1177/0145721709333493 contributor: fullname: Schemer – volume: 34 start-page: 2403 year: 2011 ident: 10.4158/EP14443.CO_bb0050 article-title: Sensor-augmented pump therapy for A1c reduction (STAR 3) study: results from the 6-month continuation phase publication-title: Diabetes Care. doi: 10.2337/dc11-1248 contributor: fullname: Bergenstal – volume: 111 start-page: 3038 year: 2014 ident: 10.4158/EP14443.CO_bb0005 article-title: Differentiated human stem cells resemble fetal, not adult, beta cells publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.1400709111 contributor: fullname: Hrvatin – volume: 363 start-page: 311 year: 2010 ident: 10.4158/EP14443.CO_bb0045 article-title: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes publication-title: N Engl J Med. doi: 10.1056/NEJMoa1002853 contributor: fullname: Bergenstal – volume: 371 start-page: 313 year: 2014 ident: 10.4158/EP14443.CO_bb0015 article-title: Outpatient glycemic control with a bionic pancreas in type 1 diabetes publication-title: N Engl J Med. doi: 10.1056/NEJMoa1314474 contributor: fullname: Russell – volume: 36 start-page: 1851 year: 2013 ident: 10.4158/EP14443.CO_bb0020 article-title: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas publication-title: Diabetes Care. doi: 10.2337/dc12-1965 contributor: fullname: Kovatchev – volume: 369 start-page: 224 year: 2013 ident: 10.4158/EP14443.CO_bb0025 article-title: Threshold-based insulin-pump interruption for the reduction of hypo-glycemia publication-title: N Engl J Med. doi: 10.1056/NEJMoa1303576 contributor: fullname: Bergenstal – volume: 15 start-page: 722 year: 2013 ident: 10.4158/EP14443.CO_bb0065 article-title: Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison publication-title: Diabetes Technol Ther. doi: 10.1089/dia.2013.0049 contributor: fullname: Luijf |
SSID | ssj0020918 |
Score | 2.1017387 |
Snippet | The holy grail for the treatment of type 1 diabetes is stem cell therapy (1,2) or the closed-loop artificial pancreas (3,4). Whereas several groups are... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 91 |
SubjectTerms | Blood Glucose Diabetes Mellitus, Type 1 - drug therapy Glycated Hemoglobin A Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Insulin Infusion Systems Insulins |
Title | A perspective of sensor-augmented insulin pump therapy in the treatment of type 1 diabetes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25297673 https://www.proquest.com/docview/1653779343 https://search.proquest.com/docview/1652422124 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELbYXQlxQbwpLCsjuJpN_IidE8p2XVpE2yhNUJdLlPhxbBe2-_8ZN24RB7hFiZNI44m_75txZhD6mHjwGukSQvNMEM4oIz0gHUlcKjvjZMp9-N95vsimDf-6FusYcLuL2yoPa-J-obZbE2Lkl2kmQm08xtnn258kdI0K2dXYQuMEndGUhzTt2ZVelNVRcgEaqqFiakJUnq6HAqUAWupSl6AlOPs0Xv4NSf_gmXu8mTxBjyNRxMUws0_RA7d5hh7OYyr8OfpR4FJXq1KP69l3jZcTvNKL1bIiRfMlFOjX1xiEefNttsBlMy9xPdVVUd7AyXCI60oXdRgX7qxvSo1TfD0rrnStVy9QM9H1eEpiowRiQFTuCFCazDPf907mWe54Z5SXgveZ7zpnnUiCKOsokCvLOqmcUN7klnnBjPReKPYSnW62G_caYa6oUdJTKy3lyoL-AxtZI7kFKeuMHaEPB1u1t0M9jBZ0RLBoGy3ajpcjdH4wYxu_ibv2zwyO0PvjZfDmkKLoNm57vx8DnAHglI_Qq8H8x9dQQYE7Sfbm_w9_ix4BqRFDmOQcne5-3bt3QBx2_QU6kWt5EX3kN19fuUY |
link.rule.ids | 315,786,790,4043,12083,21416,27954,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nc9MwEN2BMgNcmPIdaEEMXEVtS7LkE-OmCgk0iSexmbQXj62PY1Jo-v9ZxU47PcDNY8n2zNNa-96uvQvwJfJoNdJFNMlSQTlLGG3R09HIxbIxTsbch_-dp7N0XPEfK7HqA27X_WeV-z1xt1HbjQkx8pM4FaE2HuPs29VvGrpGhexq30LjITziDIfQnuXqTnChL1RdvdSIqixedeVJ0WWpE12gkuDs63B-3yH9g2XuvM3oEJ71NJHk3bo-hwdu_QIeT_tE-Eu4zEmhF8tCD8vJL03mI7LUs-V8QfPqeyjPr88IyvLqfDIjRTUtSDnWi7y4wJPhkJQLnZdhXriyvCg0icnZJD_VpV6-gmqky-GY9m0SqEFJuaVIaFLPfNs6maWZ441RXgrepr5pnHUiCpKsSZBaWdZI5YTyJrPMC2ak90Kx13Cw3qzdWyBcJUZJn1hpE64sqj_EyBrJLQpZZ-wAPu-xqq-6ahg1qoiAaN0jWg_nAzjaw1j3b8R1fbd-A_h0O4y2HBIUzdptbnZzkDGgM-UDeNPBf_uYRCTInCR79_-bf4Qn43J6XiO-P9_DU6Q3oguYHMHB9s-NO0YKsW0_7OzkL5YkueY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVgV1pxQXxTdgEjuJomsR07J5RtXVqgbZQmqLuXKPHHsV12u_-fceMWcYBblDiJ9DzxvOeZzCD0KXJgNcJGJMlSThhNKOnA05HIxqLVVsTM-f-d54t0WrNva74O-U93Ia3ysCbuF2qz1X6PfBin3NfGo4wOXUiLKMaTLze_iO8g5SOtoZ3GQ3QqWMpBiJ1eqkVRHuUXeEbZV0-NiMzidV-sFByYHKoCdAWjn0fLv93TPzjn3vdMnqDHgTTivJ_lp-iB3TxDZ_MQFn-OrnNcqHJVqFE1-6nwcoJXarFaliSvv_pi_WqMQaTXP2YLXNTzAldTVebFFZz0h7gqVV75cf7O6qpQOMbjWX6pKrV6geqJqkZTEpomEA0Cc0eA3qSOuq6zIkszy1otneCsS13bWmN55AVamwDRMrQV0nLpdGao41QL57ikL9HJZruxrxFmMtFSuMQIkzBpQAsCRkYLZkDWWm0G6OMBq-amr43RgKbwiDYB0Wa0HKCLA4xN-D7umj-zOUAfjpfBsn24ot3Y7f1-DPAHcK1sgF718B9fk_AEeJSgb_7_8PfoDIykAXi_n6NHwHV4v3tygU52t_f2LfCJXfcuGMpvB8W_iQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Perspective+of+Sensor-Augmented+Insulin+Pump+Therapy+in+The+Treatment+of+Type+1+Diabetes&rft.jtitle=Endocrine+practice&rft.au=Rayfield%2C+Elliot+J.&rft.date=2015&rft.issn=1530-891X&rft.volume=21&rft.issue=1&rft.spage=91&rft.epage=92&rft_id=info:doi/10.4158%2FEP14443.CO&rft.externalDBID=n%2Fa&rft.externalDocID=10_4158_EP14443_CO |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-891X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-891X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-891X&client=summon |